185750.KS
Chong Kun Dang Pharmaceutical Corp.
KSC · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 65,400.00
−0.30%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 13.37x
- P/E 2027E
- 11.11x
- P/E 2028E
- 9.82x
- P/S forward
- 0.47x
Trailing multiples
Trailing twelve months
- P/E TTM
- 10.84x
- PEG TTM
- —
- Price / book
- 0.89x
- Price / sales
- 0.51x
- Price / cash flow
- 7.32x
Enterprise value
- Enterprise value
- KRW 1.01T
- EV / sales
- 0.57x
- EV / EBITDA
- 8.18x
- EV / EBIT
- 13.13x
- Market cap
- KRW 902.7B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026